Preliminary experience of ex-vivo expanded allogeneic universal donor TGFbi NK cell infusions in combination with irinotecan, temozolomide, and dinutuximab in patients with relapsed or refractory neuroblastoma: The Allo - STING trial

被引：0

作者：

Ranalli, Mark A.

Shah, Nilay

Skeens, Micah

Streby, Keri A.

Lamb, Margaret

Cole, Lindsay A.

Lee, Dean Anthony

机构：

[1] Nationwide Childrens Hosp, Columbus, OH USA

[2] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH USA

[3] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Childhood Canc, Columbus, OH USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10005

引用

页数：1